Description: Presenters discuss: [1] market-value accounting, [2] accounting for mortgage-backed securities [MBSs] and collateralized mortgage obligations [CMOs], [3] the emergence of earnings under FAS 60 and FAS 97 products, and [4] effectively communicating financial results to management. Session 10 of the 1992 Valuation Actuary Symposium.

Description: This session at the 1997 Valuation Actuary Symposium discusses the history and current isses with Risk Based Capital as it applies to health insurance.

Description: 1993 SOA Spring Meeting, Boston. This session addressed the new risk-based capital requirement. Topics included: 1. How reasonable is the framework of basing the formulas on simplistic application of the C-1, C-2, C-3, and C-4 risks? 2. Will this be effective in stanching the proliferation of RBC formulas by the regulatory bodies? 3. Which lines of business are treated relatively badly by the formulas? 4. Is there realistically anything that can be done to prevent company comparisons and renkings? 5. What are the administrative problems faced by the regulators in the oversight process requirement that this will create?

Description: 1988 Valuation Actuary Symposium. This session discussed the current thinking of the Special Advisory Committee on the Valuation Law which was formed by the NAIC to significantly expand the scope and usefulness of the proposed actuarial opinion.

Description: 1988 Valuation Actuary Symposium. The speakers in this session addressed the relative volatility of participating whole life versus universal life and the annual-premium versus single- premium basis.

Description: The article provides an introduction to tax accounting for U.S. life insurance companies, with a focus on NAIC statutory accounting concepts. The author discusses permanent and temporary differences, the current tax provision, and deferred tax accounting requirements, including admissibility testing under SSAP No. 101.

Description: As the Valuation Manual continues to evolve and PBR standards for additional products are drafted and incorporated, it will become increasingly important for companies to understand where the requirements are consistent across products, as well as how they differ. This session will scan the life (VM-20) and annuity (VM-21, VM-22) PBR standards across the Valuation Manual to compare and contrast key requirements. Attendees will understand where common methods and techniques can be used across products and platforms. Attendees will also be better positioned to consider assumption and margin setting, asset and derivative modeling, and model efficiency techniques for all types of principles-based valuations. Additionally, this session will profile specific challenges that can arise when actuaries use models to project PBR reserves at future dates for internal planning, pricing, and projections across life and annuity businesses.

Description: This session at the SOA 1990 Annual Meeting is about techniques, methods, and assumptions for projecting cash flows for reserve analysis with emphasis on year-end reporting and communicating results. New York Regulation 126, proposed changes to the Standard Valuation Law, and actuarial standards of practice are discussed.

Description: This session from the 1984 SOA Atlanta Meeting covers statutory reporting, GAAP reporting, management reporting and accounting treatment of new generation life and annuity products such as universal Life, UL and flexible premium annuities. It also discusses the NAIC proposed regulation for univeral life insurance and the actuarial opinion required under the regulation.

Description: The valuation manual is a living document that continues to evolve. As more companies adopt Principle-Based Reserving (PBR) and file PBR Actuarial Reports, regulators have observed gaps and inconsistencies across the industry. As a result, PBR reporting requirements (VM-31) have expanded significantly in 2020 and still continue to evolve. This session will provide attendees with everything they need to fill out their PBR reports for both Life business and Variable Annuity business. We will dig into the new changes effective for 2020 reporting and approved changes for 2021, and compare and contrast the Life and VA requirements to help companies identify areas that can be leveraged between the two. In addition, we will share insights from regulators, consultants, and company actuaries on what to include or exclude in your report.